Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Solar Fund Regulatory News (FSFL)

Share Price Information for Foresight Solar Fund (FSFL)

Share Price is delayed by 15 minutes
Get Live Data
73.00    0.60 (0.83%)
Bid:
71.40
Ask:
73.00
Spread: 1.60 (2.241%)
Market Cap: £398.13m
FSFL Live PriceLast checked at - London Stock Exchange

Intraday Foresight Solar Fund Share Chart

Foresight Solar - Project Lorca Debt Refinancing

29 Mar 2022 07:00

RNS Number : 3080G
Foresight Solar Fund Limited
29 March 2022
 

 

29 March 2022

 

Foresight Solar Fund Limited

("Foresight Solar" or "the Company")

Project Lorca debt refinancing

 

Foresight Solar, a fund investing in a diversified portfolio of ground-based solar PV and battery storage assets in the UK and internationally, is pleased to announce that it has reached completion on a €28.0 million senior debt facility for the 98.5MW Lorca portfolio ("Project Lorca") in Granada, Spain, secured on attractive terms.

The senior debt facility will be provided by BayernLB (the "Lender") and enables Foresight Solar to obtain a long debt structuring tenor. The interest rate is fixed at a competitive rate to the market. The debt facility enables Project Lorca to optimise its capital structure and deliver higher cash yields whilst complying with financial covenants and debt service coverage ratios.

Following this transaction, the Company's total outstanding debt is £538.0 million, representing approximately 45.9% of Gross Asset Value ("GAV") of the Company and its subsidiaries based on the Company's 31 December 2021 GAV of £1,172.0 million. This is within the 50% limit on total gearing of the Company's GAV outlined in the prospectus.

The refinancing is the latest step in the development of Project Lorca which is currently under construction and is on track to be grid connected and exporting electricity by June 2022. In late 2021, the Project entered into a ten-year fixed price Power Purchase Agreement ("PPA") with Norway-based Statkraft, Europe's largest producer of renewable energy. The PPA provides the portfolio with a long-term hedge for approximately 70% of its annual production and increases the Company's revenue visibility.

 

For further information, please contact:

Foresight Group

 

Nish Sivarajan

+44 (0)20 3911 2318

(InstitutionalIR@ForesightGroup.eu)

 

 

 

Jefferies International Limited

+44(0)20 7029 8000

Neil Winward

 

Gaudi Le Roux

 

 

 

Citigate Dewe Rogerson

+44(0)20 7638 9571

Toby Moore

 

Lucy Eyles

 

Lucy Gibbs

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUGCWUPPGRR
Date   Source Headline
4th May 20217:00 amRNSAcquisition of First Battery Storage Asset
31st Mar 202110:54 amRNSDirector Declaration
11th Mar 20212:30 pmRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNSAnnual Results to 31 December 2020
2nd Mar 20215:20 pmRNSListing pursuant to Scrip Alternative and TVR
19th Feb 20217:00 amEQSEdison Investment Research Limited: Foresight Solar Fund (FSFL): Initiation - Solar energy - the future is here
15th Feb 20214:51 pmRNSResult of General Meeting
11th Feb 20211:20 pmRNSScrip Share Price
8th Feb 20217:00 amRNSNotice of Results
28th Jan 20217:00 amRNSChange to Investment Policy and Notice of GM
27th Jan 20217:00 amRNSDeclaration of Dividend
4th Jan 20217:00 amRNSAcquisition of Spanish solar portfolio
8th Dec 20204:21 pmRNSHolding(s) in Company
2nd Dec 202012:09 pmRNSTotal Voting Rights
2nd Dec 202012:01 pmRNSDirector Shareholding
24th Nov 20207:00 amRNSListing pursuant to Scrip Alternative and TVR
13th Nov 20204:34 pmRNSDirector Shareholding
13th Nov 20207:00 amRNSQ3 2020 Net Asset Value and Operational Update
6th Nov 20209:12 amRNSScrip Share Price
4th Nov 20203:14 pmRNSHolding(s) in Company
7th Oct 20209:25 amRNSHolding(s) in Company
11th Sep 20202:43 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSAcquisition of First Spanish Solar Asset
3rd Sep 20207:00 amRNSInterim Results to 30 June 2020
2nd Sep 20203:00 pmRNSDirector/PDMR Shareholding
26th Aug 202012:07 pmRNSAdditional listing pursuant to Scrip Alternative
25th Aug 20203:41 pmRNSAppointment of Non-Executive Director
21st Aug 20201:46 pmRNSHolding(s) in Company
6th Aug 20202:39 pmRNSScrip Share Price
4th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSDeclaration of Dividend
16th Jul 20204:24 pmRNSResult of 2020 Annual General Meeting
8th Jul 20203:13 pmRNSDirector Shareholding
23rd Jun 20207:00 amRNSNotice of 2020 Annual General Meeting
1st Jun 202011:04 amRNSTotal Voting Rights
26th May 20204:04 pmRNSAdditional listing pursuant to Scrip Alternative
11th May 20202:33 pmRNSScrip Share Price
4th May 20207:00 amRNSQ1 2020 Net Asset Value and Operational Update
27th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20207:00 amRNSAppointment of Corporate Broker
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSAnnual Results to 31 December 2019
27th Feb 20207:00 amRNSAdditional listing pursuant to Scrip Alternative
26th Feb 20207:00 amRNSRestructuring of Investment Management Arrangement
19th Feb 20207:00 amRNSQ4 2019 Net Asset Value
6th Feb 20201:59 pmRNSScrip Share Price
3rd Feb 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.